Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Richard Oakley

Low psychological wellbeing may raise risk of dementia, study suggests

Lacking life purpose and growth opportunities may raise risk of mild cognitive impairment, a frequent precursor of dementia

The Guardian - UK

Ten-minute brain scan could detect dementia early, study suggests

Scan could become routine procedure in memory clinics if findings confirmed in larger cohort, scientists say

The Guardian - UK

Non-invasive deep brain stimulation ‘could provide treatment for brain diseases’

Until now, if experts wanted to electrically stimulate structures deep inside the brain, they needed to surgically implant electrodes into the brain.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Why is this Alzheimer’s breakthrough so important?

Your questions answered on donanemab.

The Independent UK

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

Evening Standard

‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Experts urge health regulators to approve ‘turning point’ dementia drugs

Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial

The Guardian - UK

‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Hope for Alzheimer's patients as doctors develop drug to slow effect of illness

Experts said 'this could be the beginning of the end' of the disease after donanemab slowed brain decline by 36% in a late-stage clinical trial

Daily Mirror

World ‘on cusp of first generation of treatments for Alzheimer’s’

Almost half of those on donanemab had no clinical progression of disease at one year compared with 29% on a placebo, a study showed.

Evening Standard

World ‘on cusp of first generation of treatments for Alzheimer’s’ as new drug ‘slows symptoms’

New drug donanemab appears to slow decline associated with Alzheimer’s

The Independent UK

World ‘on cusp of first generation of treatments for Alzheimer’s’ as new drug found

Almost half of those on donanemab had no clinical progression of disease at one year compared to 29% on placebo, a study showed.

The Independent UK

Seven healthy habits ‘may help cut the risk of dementia’, long-term study suggests

As new research suggests lifestyle factors can cut the chances of developing dementia, Lisa Salmon speaks to the Alzheimer’s Society about them.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Victims of racism more likely to suffer poorer brain function and memory loss in later life, study suggests

Evidence shows that Black people are more at risk of dementia but less likely to receive a timely diagnosis due to barriers in accessing healthcare.

The Independent UK

Single brain scan could diagnose Alzheimer’s disease, study suggests

With no cure for Alzheimer’s, an early diagnosis allows patients to access help and support.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

207 stories

Alzheimer Research UK

101 stories

DRI

91 stories

Queen Mary University of London

63 stories

Eli Lilly and Company

49 stories

the University of Surrey

17 stories

Imperial College Healthcare NHS Trust

16 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.